Morgan Stanley’s ClearPoint Neuro CLPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.97M Buy
332,323
+174,353
+110% +$2.08M ﹤0.01% 4241
2025
Q1
$1.88M Buy
157,970
+73,631
+87% +$875K ﹤0.01% 4642
2024
Q4
$1.3M Buy
84,339
+37,512
+80% +$577K ﹤0.01% 4953
2024
Q3
$525K Sell
46,827
-43,372
-48% -$486K ﹤0.01% 5381
2024
Q2
$486K Sell
90,199
-63,752
-41% -$344K ﹤0.01% 5309
2024
Q1
$1.05M Sell
153,951
-170,027
-52% -$1.16M ﹤0.01% 4930
2023
Q4
$2.2M Buy
323,978
+205,284
+173% +$1.39M ﹤0.01% 4873
2023
Q3
$595K Buy
118,694
+49,156
+71% +$246K ﹤0.01% 5090
2023
Q2
$503K Sell
69,538
-25,803
-27% -$187K ﹤0.01% 5207
2023
Q1
$805K Buy
95,341
+1,754
+2% +$14.8K ﹤0.01% 4983
2022
Q4
$793K Sell
93,587
-10,077
-10% -$85.4K ﹤0.01% 4991
2022
Q3
$1.07M Sell
103,664
-24,047
-19% -$249K ﹤0.01% 4842
2022
Q2
$1.67M Sell
127,711
-49,001
-28% -$639K ﹤0.01% 4670
2022
Q1
$1.84M Buy
176,712
+50,416
+40% +$525K ﹤0.01% 4579
2021
Q4
$1.42M Buy
126,296
+113,360
+876% +$1.27M ﹤0.01% 4835
2021
Q3
$230K Sell
12,936
-18,641
-59% -$331K ﹤0.01% 5924
2021
Q2
$603K Sell
31,577
-36,097
-53% -$689K ﹤0.01% 5407
2021
Q1
$1.43M Buy
67,674
+59,641
+742% +$1.26M ﹤0.01% 4500
2020
Q4
$127K Buy
8,033
+7,033
+703% +$111K ﹤0.01% 5809
2020
Q3
$5K Buy
+1,000
New +$5K ﹤0.01% 6436
2020
Q2
Sell
-500
Closed -$2K 6612
2020
Q1
$2K Hold
500
﹤0.01% 6374
2019
Q4
$2K Sell
500
-1,054
-68% -$4.22K ﹤0.01% 6493
2019
Q3
$8K Buy
+1,554
New +$8K ﹤0.01% 6266